Queen's University at Kingston, commonly known as Queen's University or simply Queen's, is a public research university in Kingston, Ontario, Canada. Queen's holds more than 1,400 hectares of land throughout Ontario and owns Herstmonceux Castle in East Sussex, England.

During the past decade, Queen's University conducted 61 clinical trials. In the 10-year time frame, 61 clinical trials started and 10 clinical trials were completed, i.e. on average, 16.4% percent of trials that started reached the finish line to date. In the past 5 years, 30 clinical trials started and 6 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Queen's University" #1 sponsor was "Queen's University" with 43 trials, followed by "National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)" with 5 trials sponsored, "University of British Columbia" with 5 trials sponsored, "McMaster University" with 3 trials sponsored and "University Health Network, Toronto" with 3 trials sponsored. Other sponsors include 43 different institutions and companies that sponsored additional 47 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Queen's University" #1 collaborator was "Canadian Institutes of Health Research (CIHR)" with 12 trials as a collaborator, "Queen's University" with 7 trials as a collaborator, "University of Calgary" with 7 trials as a collaborator, "McMaster University" with 5 trials as a collaborator and "McGill University" with 4 trials as a collaborator. Other collaborators include 81 different institutions and companies that were collaborators in the rest 72 trials.

According to Clinical.Site data, the most researched conditions in "Queen's University" are "Major Depressive Disorder" (9 trials), "Depression" (5 trials), "Schizophrenia" (5 trials), "Alzheimer's Disease" (3 trials) and "Interstitial Cystitis" (3 trials). Many other conditions were trialed in "Queen's University" in a lesser frequency.

Most popular intervention types in "Queen's University" are "Drug" (41 trials), "Behavioral" (32 trials), "Other" (25 trials), "Procedure" (6 trials) and "Device" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "e-CBT" (3 trials), "Aticaprant" (2 trials), "Brexpiprazole" (2 trials) and "Cognitive Remediation" (2 trials). Other intervention names were less common.

The vast majority of trials in "Queen's University" are 91 trials for "All" genders, 9 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are 26 active trials in "Queen's University". 2 are not yet recruiting, 17 are recruiting, 5 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 65 completed trials in Queen's University, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Queen's University, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 21 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 57 trials that are defined as “Not Applicable".

Queen's University has several departments that took part in Clinical trials: "Centre for Applied Urological Research" - 22 trials, "National Cancer Institute of Canada Clinical Trials Group" - 9 trials, "School of Kinesiology and Health Studies" - 5 trials, "Respiratory Investigation Unit" - 3 trials, "Queen's University, Cardiovascular Imaging Network at Queen's (CINQ), Kingston General Hospital" - 2 trials, "School of Rehabilitation Therapy, Queen's University" - 2 trials